GlaxoSmithKline Pharmaceuticals Limited — Board Meeting, 13-05-2026: Outcome of Board Meeting

GSK Pharma's board approved Q4 & FY26 consolidated results: Profit for the year reached ₹1036 Cr, with revenue at ₹3822 Cr. EPS hit ₹61.15. A final dividend of ₹57/share for FY26 was declared.